Perspective Therapeutics ...

1.95
-0.18 (-8.45%)
At close: Apr 01, 2025, 3:59 PM
2.06
5.70%
After-hours: Apr 01, 2025, 08:00 PM EDT

Perspective Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 9.24M 20.99M 55.89M 63.83M 2.39M
Short-Term Investments n/a 22.76M n/a n/a n/a
Long-Term Investments 133K 150K 182K 182K 181K
Other Long-Term Assets 182K -2.3M 2.33M 76K 137K
Receivables 1.18M 1.36M 1.61M 2.01M 2.04M
Inventory n/a 1.41M 1.4M 980K 645K
Other Current Assets 5.35M 6.69M 27K 481K 426K
Total Current Assets 16.84M 53.22M 59.33M 67.3M 5.51M
Property-Plant & Equipment 6.32M 2.06M 2.49M 2.73M 2.74M
Goodwill & Intangibles 74.42M 86K 107K 130K 138K
Total Long-Term Assets 81.05M 2.3M 5.11M 3.11M 3.19M
Total Assets 97.89M 58.09M 64.44M 70.42M 8.7M
Account Payables 6.11M 1.54M 966K 730K 654K
Deferred Revenue n/a n/a n/a n/a n/a
Short-Term Debt 49K n/a 268K 252K 236K
Other Current Liabilities 5.07M 1.14M 1.03M 819K 685K
Total Current Liabilities 15.66M 2.68M 2.27M 1.8M 1.57M
Long-Term Debt 1.68M n/a 256K 524K 769K
Other Long-Term Liabilities n/a n/a 640K 685K 632K
Total Long-Term Liabilities 7.05M n/a 896K 1.21M 1.4M
Total Liabilities 22.71M 3.45M 3.16M 3.01M 2.98M
Total Debt 2.55M n/a 524K 776K 1M
Common Stock 282K 142K 142K 142K 69K
Retained Earnings -152.44M -105.93M -98.6M -91.33M -87.94M
Comprehensive Income n/a n/a n/a n/a n/a
Shareholders Equity 75.18M 54.64M 61.28M 67.41M 5.72M
Total Investments 133K 22.91M 182K 182K 181K